News and communications

Scott Mitchell appointed People’s Champion of the national mission to beat dementia, founded in his wife Dame Barbara Windsor’s memory.

• Updated: 20 March 2024

The scheme will see the lowest-risk clinical trials processed by the MHRA in less than 14 days.

• Updated: 12 October 2023

Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.

• Updated: 5 July 2023

Around three-quarters of the £50 million funding pledged towards cutting edge research into motor neurone disease (MND) has now been handed out to projects across the UK, the government has announced today (Wednesday 21 June…

• Updated: 21 June 2023

The legislative changes will help to make the UK one of the best countries in the world to conduct clinical research for patients and researchers.

• Updated: 21 March 2023

The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia.

• Updated: 20 March 2023

Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.

• Updated: 28 November 2022

Government’s Vaccine Taskforce has granted £10.65 million in additional funding to support the launch of Darlington RNA vaccine innovation centre.

• Updated: 7 October 2022

Following its success during the COVID-19 pandemic, the functions of the Vaccine Taskforce will be embedded as a permanent part of government structures.

• Updated: 15 June 2022

People are encouraged to contribute their views on far-reaching proposed revisions to the clinical trial legislation in the UK

• Updated: 17 January 2022

This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19

• Updated: 31 December 2021

This new guidance follows consultation with stakeholders from the pharmaceutical industry, academic research, trade associations, patient organisations/charities, healthcare providers and regulatory organisations.

• Updated: 16 December 2021

Portsmouth’s Queen Alexandra Hospital is trialing a test that could reduce burden on the NHS by predicting sepsis in patients.

• Updated: 26 August 2021

Speech by Minister for Innovation Lord Bethell at the National Institute for Health Research (NIHR) Clinical Research Network National Industry Event.

• Updated: 4 March 2021

MHRA Chief Executive Dr June Raine explains the process behind the Agency's approval of the Pfizer/BioNTech vaccine

• Updated: 8 December 2020

We are reviewing the risks and benefits of the acne medicine, isotretinoin. In particular whether some of the possible psychiatric and sexual side effects continue after treatment has been stopped.

• Updated: 10 November 2020

The MHRA has approved the recruitment of further participants for a clinical trial by the University of Oxford

• Updated: 26 June 2020

The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.

• Updated: 16 June 2020

The UK organised the Global Vaccine Summit 2020 on 4 June, helping secure US$7.4 billion (approximately £6 billion) in funding to support global vaccine supply and immunisation.

• Updated: 5 June 2020

MHRA has today given the first positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for use of Gilead’s remdesivir.

• Updated: 26 May 2020